Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.

× No keyword cloud information.

8 in total

Review 1. Does rituximab increase the incidence of infectious complications? A narrative review.

Authors: Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal: Int J Infect Dis Date: 2010-11-11 Impact factor: 3.623

2. Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography.

Authors: Arutselvan Natarajan; Sanjiv Sam Gambhir
Journal: Mol Imaging Biol Date: 2015-08 Impact factor: 3.488

Review 3. Current management of mantle cell lymphoma.

Authors: Oliver Weigert; Michael Unterhalt; Wolfgang Hiddemann; Martin Dreyling
Journal: Drugs Date: 2007 Impact factor: 9.546

4. A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy.

Authors: David G Maloney; Michinori Ogura; Noriko Fukuhara; Jaclyn Davis; Janet Lasher; Miguel Izquierdo; Hiya Banerjee; Kensei Tobinai
Journal: Blood Adv Date: 2020-08-25

5. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.

Authors: Saiyada N F Rizvi; Otto J Visser; Maria J W D Vosjan; Arthur van Lingen; Otto S Hoekstra; Josée M Zijlstra; Peter C Huijgens; Guus A M S van Dongen; Mark Lubberink
Journal: Eur J Nucl Med Mol Imaging Date: 2012-01-05 Impact factor: 9.236

6. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.

Authors: Lonneke van de Poll-Franse; Simone Oerlemans; Anne Bredart; Charalampia Kyriakou; Monika Sztankay; Stephan Pallua; Laurien Daniëls; Carien L Creutzberg; Kim Cocks; Sandra Malak; Giovanni Caocci; Stefano Molica; Weichu Chie; Fabio Efficace
Journal: Qual Life Res Date: 2017-11-10 Impact factor: 4.147

7. Survival from non-Hodgkin lymphoma in England and Wales up to 2001.

Authors: P W M Johnson
Journal: Br J Cancer Date: 2008-09-23 Impact factor: 7.640

8. Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitals.

Authors: Guilherme Rossi Assis-Mendonça; André Henrique Crepaldi; Márcia Torresan Delamain; Adriana Helena Moreira; Felipe D'Almeida Costa; Vladmir Cláudio Cordeiro de Lima; Cármino Antonio de Souza; Fernando Augusto Soares; José Vassallo
Journal: Hematol Transfus Cell Ther Date: 2018-04-18

8 in total